Avraham Hochberg

492 citations
9 papers · 412 indexed · h-index 8
Topics
Epigenetics and DNA Methylation (3 papers)Pancreatic and Hepatic Oncology Research (2 papers)Urinary and Genital Oncology Studies (2 papers)
Partner nations
IsraelGermanyCanada

In The Last Decade

Avraham Hochberg

9 papers receiving 408 citations

Peers

Avraham Hochberg
Comparison fields: 5 of 58
  • Molecular Biology 303
  • Cancer Research 232
  • Surgery 47
  • Oncology 44
  • Epidemiology 40
Replace Guoqing He with:
Guoqing He China
WU Wen-xi China
Kazuki Heishima Japan
Subramanyam Chittivelu United States
Marion Gayral France
Yinghan Su China
Genesio Leo Italy
Jiantao Xiao China
M. S. Lo Piccolo Italy
Avraham Hochberg relative to Guoqing He China Guoqing He's profile →
Citations per field
00.5×1.5×
Guoqing He · 1×
Citations per year

Countries citing papers authored by Avraham Hochberg

Since Specialization
Citations

This map shows the geographic impact of Avraham Hochberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avraham Hochberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avraham Hochberg more than expected).

Fields of papers citing papers by Avraham Hochberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avraham Hochberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avraham Hochberg. The network helps show where Avraham Hochberg may publish in the future.

Co-authorship network of co-authors of Avraham Hochberg

This figure shows the co-authorship network connecting the top 25 collaborators of Avraham Hochberg. A scholar is included among the top collaborators of Avraham Hochberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avraham Hochberg. Avraham Hochberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 11
2 44
3 107
4 13
5 28
6 34
7 111
8
Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
61
9 3

About Avraham Hochberg

Avraham Hochberg is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology, having authored 9 papers that have together received 412 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Cancer Research (232 citations), Molecular Biology (303 citations) and Biotechnology (36 citations). Avraham Hochberg has collaborated with scholars based in Israel, Germany and Canada. Frequent co-authors include Michal Gilon, Eli Raveh, Imad Matouk, Patricia Ohana, Vladimir Sorin, David Halle, Ilan Leibovitch, A. Sidi, Donald L. Lamm and Shalva Benjamin. Their work appears in journals such as PLoS ONE, The Journal of Urology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026